S-3 S-3 EX-FILING FEES 0001716947 Ensysce Biosciences, Inc. N/A N/A 0001716947 2026-04-08 2026-04-08 0001716947 1 2026-04-08 2026-04-08 0001716947 2 2026-04-08 2026-04-08 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-3

Ensysce Biosciences, Inc.

Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Fees to be Paid 1 Equity Common Stock, par value $0.0001 per share ("Common Stock") underlying warrants to purchase Common Stock Other 9,981,091 $ 0.5234 $ 5,224,103.00 0.0001381 $ 721.45
Fees to be Paid 2 Equity Common Stock, par value $0.0001 per share ("Common Stock") underlying convertible Preferred Stock Other 10,354,400 $ 0.5234 $ 5,419,493.00 0.0001381 $ 748.43
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 10,643,596.00

$ 1,469.88

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 1,469.88

Offering Note

1

The shares of the Registrant's common stock, par value $0.0001 per share (the "Common Stock"), offered hereby also include such presently indeterminate number of shares of Common Stock as a result of stock splits, stock dividends or similar transactions in accordance with Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"). Pursuant to Rule 457(c) under the Securities Act, and solely for the purpose of calculating the registration fee at a fee rate of 0.00013810 ($138.10 per $1 million), the proposed maximum offering price per share is $0.5234, which is the average of the high and low prices of the Common Stock as reported on The Nasdaq Capital Market on March 31, 2026, which date is within five business days prior to filing this registration statement. Represents an aggregate of 20,335,491 shares of Common Stock registered for sale by the selling stockholders named in this registration statement consisting of: 10,354,400 shares of Common Stock issuable upon conversion of shares of the Company's Series B preferred stock, 9,607,273 shares of Common Stock underlying those certain warrants issued by the Company pursuant to a securities purchase agreement and 373,818 shares of Common Stock underlying those certain warrants issued to a financial advisor, all in certain transactions described herein (after giving effect to certain potential anti-dilution and other adjustments).

2

The shares of the Registrant's common stock, par value $0.0001 per share (the "Common Stock"), offered hereby also include such presently indeterminate number of shares of Common Stock as a result of stock splits, stock dividends or similar transactions in accordance with Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"). Pursuant to Rule 457(c) under the Securities Act, and solely for the purpose of calculating the registration fee at a fee rate of 0.00013810 ($138.10 per $1 million), the proposed maximum offering price per share is $0.5234, which is the average of the high and low prices of the Common Stock as reported on The Nasdaq Capital Market on March 31, 2026, which date is within five business days prior to filing this registration statement. Represents an aggregate of 20,335,491 shares of Common Stock registered for sale by the selling stockholders named in this registration statement consisting of: 10,354,400 shares of Common Stock issuable upon conversion of shares of the Company's Series B preferred stock, 9,607,273 shares of Common Stock underlying those certain warrants issued by the Company pursuant to a securities purchase agreement and 373,818 shares of Common Stock underlying those certain warrants issued to a financial advisor, all in certain transactions described herein (after giving effect to certain potential anti-dilution and other adjustments).

Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rules 457(b) and 0-11(a)(2)
Fee Offset Claims
Fee Offset Sources
Rule 457(p)
Fee Offset Claims
Fee Offset Sources
Table 3: Combined Prospectuses ☑Not Applicable

Security Type

Security Class Title

Amount of Securities Previously Registered

Maximum Aggregate Offering Price of Securities Previously Registered

Form Type

File Number

Initial Effective Date